drugset / Trial / NCT01616953

Cell Therapy for Craniofacial Bone Defects

NCT01616953 ↗

Phase 1/2 Completed 18 enrolled University of Michigan
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research is to determine if a patient's own bone marrow tissue can help regenerate bone in the area of the jaw where an implant will be placed. The name of the process is called Bone Repair Cell (BRC) Therapy. A sample of bone marrow tissue will be collected and sent to a laboratory where it will be processed to form more cells. These new cells will then be transplanted in the regenerative site. The researchers are testing to see if these cells (BRC) will help form bone. The research will also determine if the implant will be more stable in the area with new bone growth.

Timeline

Start
2012-08
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixmyelocel-T Cell therapy — —

Indications